Progestational therapy in human renal carcinoma and steroid receptors.
D000230:Adenocarcinoma / Q000188:drug therapy / Q000378:metabolism*; D001667:Binding, Competitive; D003600:Cytosol / Q000378:metabolism; D004958:Estradiol / Q000378:metabolism; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology; D007668:Kidney / Q000378:metabolism*; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D007700:Kinetics; D008297:Male; D009362:Neoplasm Metastasis; D009644:Norgestrel / Q000378:metabolism; D011374:Progesterone / Q000378:metabolism / Q000627:therapeutic use*; D011960:Receptors, Estrogen / Q000378:metabolism*; D011980:Receptors, Progesterone / Q000187:drug effects / Q000378:metabolism*
D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D009644:Norgestrel; D011374:Progesterone; D004958:Estradiol; D006854:Hydrocortisone